Clinical Trials Logo

Bone Neoplasm clinical trials

View clinical trials related to Bone Neoplasm.

Filter by:

NCT ID: NCT06376539 Not yet recruiting - Rehabilitation Clinical Trials

Functional Recovery of Patients Undergoing Resection and Reconstruction of the Lower Limbs for Bone Tumor.

FISIO-ONCO
Start date: May 2024
Phase:
Study type: Observational

The aim of the present study is to describe the course of functional recovery of patients with musculoskeletal tumours and undergone resection and reconstruction operations of lower limbs in the first six months post-surgery, differentiating them on the basis of the anatomical level involved.

NCT ID: NCT05881343 Completed - Clinical trials for Coronavirus Infection

Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic Surgery

COVID19&SURG
Start date: July 18, 2020
Phase:
Study type: Observational

Over the last months, the Rizzoli Orthopedic Institute in Bologna, Italy, has drained orthopedic urgencies from all other hospitals in the urban and suburban area. In this context urgencies are defined as fractures and primary or metastatic bone lesions with indication to non-deferrable surgery. A subset of these patients tested positive for SARS CoV 2, either before or after the surgical procedure. Anesthesiological clinical management of covid19 cases is complicated by the consequences of the viral infection on respiratory and cardio-vascular systems, renal function and coagulation. Similarly, management of asymptomatic patients is challenging because of the lack of data on possible specific complications. This study will report a snapshot of our early experience on perioperative clinical management of patients undergoing orthopedic surgery in the presence of SARS CoV 2 infection, ascertained or not at the time of surgery.

NCT ID: NCT05310539 Recruiting - Bone Neoplasm Clinical Trials

Early Recovery After "Wedge Resection" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.

Start date: January 8, 2022
Phase:
Study type: Observational

After "wedge resection" surgery, the physiotherapy programs proposed in the literature are heterogeneous and there are few data on the outcomes of such treatments in an oncological population for bone cancer. The aim of the study is to describe the early rehabilitation process after wedge resection surgery secondary to bone tumor pulmonary mestasasis, highlightining the possible functional recovery in the short and medium term after surgery and indentifying the possible prognostic factors.

NCT ID: NCT04884048 Completed - Bone Neoplasm Clinical Trials

Multicentric Bone Tumor Imaging Report and Data System

BTI-RADS M
Start date: May 1, 2021
Phase:
Study type: Observational

In this study a previously described structured multimodality image report system for the characterization of focal bone lesions is evaluated in a larger patient population. The objective of this study is to evaluate the performance of this tool stratifying the malignancy risk of bone tumors.

NCT ID: NCT04394052 Recruiting - Bone Neoplasm Clinical Trials

Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II

TUMOSTEO II
Start date: June 1, 2020
Phase:
Study type: Observational

This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.

NCT ID: NCT04310410 Completed - Pain Clinical Trials

Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis

PRE-FURTHER
Start date: April 11, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The PRE-FURTHER study aims to evaluate the feasibility of the combined treatment with radiotherapy and focussed ultrasound for pain palliation in patients with painful bone metastases, and to optimize the combined treatment logistics. Six to ten patients will be included according to in- and exclusion criteria.

NCT ID: NCT04307914 Recruiting - Pain Clinical Trials

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases

FURTHER
Start date: March 10, 2020
Phase: N/A
Study type: Interventional

The FURTHER study aims to evaluate the effectiveness and cost-effectiveness of MR-HIFU (alone or in combination with EBRT) compared to EBRT alone, the standard-of-care, as a palliative treatment option to relieve CIBP. The FURTHER study consists of a multicenter, three-armed randomized controlled trial (FURTHER RCT) and a patient registry arm (FURTHER Registry), which will be performed in six hospitals in four European countries.

NCT ID: NCT04074291 Completed - Quality of Life Clinical Trials

Cross Cultural Validation of the Italian Version of the Bt-DUX

Start date: August 20, 2019
Phase:
Study type: Observational

The purpose of the presented study is to translate the English Bt-DUX (Bt-DUX-Eng) questionnaire into the Italian language and then examine the validity of the Italian version of the Bt-DUX (Bt-DUX-It).

NCT ID: NCT03678883 Active, not recruiting - Cancer Clinical Trials

9-ING-41 in Patients With Advanced Cancers

Start date: January 4, 2019
Phase: Phase 2
Study type: Interventional

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers.

NCT ID: NCT03442465 Recruiting - Osteosarcoma Clinical Trials

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Start date: February 14, 2018
Phase:
Study type: Observational

The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who have tumor surgery plus regenerative osseous surgery. The study will look at the level of function for a period of 3 years after the surgery. Another purpose of this study is to look at how well the bone heals in participants undergoing regenerative surgery